Who Is This Treatment For? Chronic spontaneous urticaria, aka CSU, happens when a person develops itchy hives that persist for over six weeks. Their condition may not consistently be controlled by ...

Therefore, it is important for individuals to speak with a doctor about hives that keep returning. Keep reading to learn more about the symptoms, causes, diagnosis, and treatment of hives that ...

Dupixent, which was rejected by the FDA for chronic spontaneous urticaria in October 2023, is now approved as the first new ...

The CSU indication is the seventh disease driven in part by underlying type 2 inflammation in which Dupixent has received approval.

CHRONIC spontaneous urticaria (CSU) is a distressing inflammatory skin condition characterised by the recurrent appearance of ...

A new study published in the Journal of American Medical Association showed that Rilzabrutinib decreased itching and hives ...